finance.yahoo.comDenali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Nowabout 1 year ago
finance.yahoo.comDenali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)about 1 year ago
finance.yahoo.comDenali Therapeutics (NASDAQ:DNLI) shareholders are up 3.4% this past week, but still in the red over the last three yearsabout 1 year ago
finance.yahoo.comDenali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administrationabout 1 year ago
finance.yahoo.comDenali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlightsabout 1 year ago
finance.yahoo.comFlagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizerover 1 year ago
finance.yahoo.comCompanies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growthover 1 year ago
benzinga.comStericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Mondayover 1 year ago
finance.yahoo.comDenali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapiesover 1 year ago
CashuDenali Therapeutics Faces Extended FDA Review for Hunter Syndrome Treatment Tividenofusp Alfa1 day ago
CashuDenali Therapeutics Faces Extended FDA Review for Hunter Syndrome Drug Tividenofusp Alfa4 days ago
CashuDenali Therapeutics Faces Extended FDA Review for Hunter Syndrome Treatment Tividenofusp Alfa6 days ago